Henry Schein Dental Announces Sleep Complete™ Dental Sleep Medicine Training Programs
Events Provide Training For Successfully Integrating Dental Sleep Medicine into the Practice
Posted on June 27, 2014
MELVILLE, N.Y., June 27, 2014 — Henry Schein Dental, the U.S. dental business of Henry Schein, Inc. (NASDAQ: HSIC), the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, announced today a schedule of upcoming Sleep Complete™ Dental Sleep Medicine training programs taking place throughout the remainder of 2014.
Entitled “Saving Lives and Growing Your Practice through Dental Sleep Medicine – An Implementation Symposium,” the two-day program will provide dental practitioners and their teams with training on how to integrate and implement dental sleep medicine into their practices. Dental sleep medicine can empower practitioners to provide treatment for Obstructive Sleep Apnea (OSA) and improve the quality of life for their patients. According to research from The American Academy of Sleep Medicine’s Journal of Clinical Sleep Medicine,1 moderate to severe obstructive sleep apnea can be four times as fatal when the sleep disorder is left untreated in the long term.
Over the course of the program, attendees can earn up to 16 continuing education credits while learning about OSA and dental sleep medicine implementation. Topics include: Screening techniques for OSA; Oral Appliance Therapy selection for OSA; Oral Appliance design and fabrication; Office Systems and Workflows; Documentation, Medical Billing and Reimbursement; and Communicating with physicians and sleep laboratories.
For more information and to register, please email email@example.com
Upcoming training dates and locations include:
-- July 11-12, Sacramento, CA;
-- July 18-19, Denver, CO;
-- Aug. 1-2, Dallas, TX;
-- Aug. 8-9, Columbus, OH;
-- Aug. 15-16, Virginia Beach, VA;
-- Sept. 19-20, Madison, WI;
-- Oct. 3-4, Cincinnati, OH;
-- Oct. 17-18, Portland, OR;
-- Oct. 24-25, Northern Los Angeles, CA;
-- Nov. 7-8, Long Island, NY;
-- Nov. 14-15, Tulsa, OK;
-- Nov. 21-22, Grand Rapids, MI;
-- Dec. 12-13 in Detroit, MI.
Attendees already possessing introductory knowledge about dental sleep medicine can further their education by attending a Phase II program, entitled “Saving Lives and Growing Your Practice Through Dental Sleep Medicine – Continuing the Journey.” A Phase II training program is scheduled to take place September 26-27, location to be confirmed and more dates to be scheduled.
1. Marshall NS; Wong KK; Cullen SR; Knuiman MW; Grunstein RR. Sleep apnea and 20-year follow-up for all-cause mortality, stroke, and cancer incidence and mortality in the Busselton health study cohort. J Clin Sleep Med 2014;10(4):355-362. http://dx.doi.org/10.5664/jcsm.3600
About Henry Schein, Inc.
Henry Schein, Inc. is the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners. The Company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites. A Fortune 500® Company and a member of the NASDAQ 100® Index, Henry Schein employs nearly 17, 000 Team Schein Members and serves more than 800,000 customers.
The Company offers a comprehensive selection of products and services, including value-added solutions for operating efficient practices and delivering high-quality care. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 96,000 branded products and Henry Schein private-brand products in stock, as well as more than 110,000 additional products available as special-order items. The Company also offers its customers exclusive, innovative technology solutions, including practice management software and e-commerce solutions, as well as a broad range of financial services.
Headquartered in Melville, N.Y., Henry Schein has operations or affiliates in 27 countries. The Company's sales reached a record $9.6 billion in 2013, and have grown at a compound annual rate of approximately 16 percent since Henry Schein became a public company in 1995. For more information, visit the Henry Schein website.